Come up with a name for your new list and we'll add to it:
MecRx raised a round of funding on March 23, 2016. Investors include
Brandon Capital Partners.
MecRx is an early stage drug development company working on new treatments for cancer. Using proprietary 'hit identification' technology, MecRx is developing inhibitors of cMyc, a protein that is dere…